Century Therapeutics, Inc.
IPSC
$2.44
$0.146.09%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 117.11M | 132.75M | 155.84M | 165.12M | 189.29M |
| Total Receivables | 667.00K | 484.00K | 626.00K | 983.00K | 1.52M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 520.00K | 4.48M | 3.70M | 3.53M | 1.53M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.47M | -- | -- | -- | 1.71M |
| Total Current Assets | 120.77M | 137.71M | 160.17M | 169.63M | 194.05M |
|
|
|||||
| Total Current Assets | 120.77M | 137.71M | 160.17M | 169.63M | 194.05M |
| Net Property, Plant & Equipment | 66.17M | 70.28M | 84.39M | 87.76M | 90.85M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 34.20M | 34.20M | 34.20M | 34.20M | 34.20M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.57M | 2.53M | 3.25M | 3.30M | 3.30M |
| Total Assets | 223.70M | 244.72M | 284.69M | 315.61M | 353.22M |
|
|
|||||
| Total Accounts Payable | 4.77M | 2.62M | 3.21M | 3.57M | 3.08M |
| Total Accrued Expenses | 8.35M | 7.28M | 6.83M | 6.05M | 12.59M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.32M | 3.77M | 4.89M | 4.88M | 4.87M |
| Total Finance Division Other Current Liabilities | 3.78M | 8.36M | 20.00K | -- | 109.25M |
| Total Other Current Liabilities | 3.78M | 8.36M | 20.00K | -- | 109.25M |
| Total Current Liabilities | 20.23M | 22.03M | 14.95M | 14.50M | 129.78M |
|
|
|||||
| Total Current Liabilities | 20.23M | 22.03M | 14.95M | 14.50M | 129.78M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 40.24M | 41.19M | 46.59M | 47.79M | 48.96M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 4.30M | 5.16M | 13.26M | 12.87M | 13.11M |
| Total Liabilities | 64.77M | 68.37M | 74.79M | 75.17M | 191.85M |
|
|
|||||
| Common Stock & APIC | 950.82M | 949.02M | 948.13M | 945.91M | 943.38M |
| Retained Earnings | -791.92M | -772.74M | -738.32M | -705.78M | -782.34M |
| Treasury Stock & Other | 30.00K | 64.00K | 83.00K | 305.00K | 324.00K |
| Total Common Equity | 158.94M | 176.35M | 209.90M | 240.44M | 161.36M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 158.94M | 176.35M | 209.90M | 240.44M | 161.36M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 158.94M | 176.35M | 209.90M | 240.44M | 161.36M |
|
|
|||||